Some think investing in stocks requires substantial start-up capital, but that's false. Even with a modest sum, like $40, ...

Jim Fan tells AI community don’t worry. Be happy…and grind on code 24-7. Faster is the only way. Many tech folks are panicking about how much DeepSeek is able to show with so little compute budget. I ...

It’s more than a financial blow; it’s a betrayal of the families who are depending on breakthroughs in cancer treatment, ...

The main floor hosted six stages: Start-Up, Biotech Growth (pre-Series B), Biotech ... Levin remarked that 2022 feels similar to the long grind witnessed in 2010, with budgets stretched in ...

Find and fix vulnerabilities Actions ...

The latest example of this trend is Merck KGaA’s impending all-cash acquisition of SpringWorks Therapeutics, valued around ...

The NIH says funding cuts would save it billions of dollars a year. D.C.-area industry and academic leaders say it would cripple R&D.

Though most biopharma investment is in two states, follow this model to bring the research—and investments—elsewhere.

Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...

Bambusa Therapeutics has raised about $90 million to build out a pipeline of next-gen bispecific antibodies targeting ...

A Hong Kong biotech start-up is working with a number of university partners to conduct global clinical trials that could lead to a better way of delivering drugs for prevalent eye diseases.